Dear Friends and Colleagues,
IPOPI was delighted to have you all at the 4th edition of the International Primary Immunodeficiencies Congress – IPIC2019 – held in the lively city of Madrid, Spain, at the Marriot Auditorium, on 6-8 November 2019.
We were excited to be back in Europe for the 2019 edition, building on our previous events and with the promise to deliver a diverse and stimulating scientific programme focusing on the state of the art in primary immunodeficiencies (PID) diagnosis and clinical care.
750 people were in attendance and benefited from a well-balanced and appealing scientific programme that was clinically orientated and prepared with the input from the key PID stakeholders: doctors, patients and nurses.
The congress programme featured world-renowned experts in the field of PID as well as other key stakeholders who shared their invaluable experience and unique perspectives on major clinical developments and advances in the field.
The programme engaged international delegates through interactive sessions and pertinent topics such as:
- Management of respiratory issues in PID
- Novel PID diagnostics
- Management of complex PID cases
- Regional clinical priorities
- Gene therapy developments
- Managing PID in adulthood and old age
- Ethical issues around PID care and diagnosis
- Perspectives on future care and diagnosis developments
The next International Primary Immunodeficiencies Congress has now been announce – IPIC2021 will be held in Berlin, Germany, on 3-5 November 2021.
We hope to see you there! More details www.IPIC2021.com
Congress Organising Committee President
Dr Nizar Mahlaoui
Congress Scientific Committee President